{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:22:27Z","timestamp":1793226147388,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["DNW-19015"],"award-info":[{"award-number":["DNW-19015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118104","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:01:54Z","timestamp":1745852514000},"page":"118104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Drug repositioning: Identification of potent inhibitors of NS3 protease and NS5 RdRp for control of DENV infection"],"prefix":"10.1016","volume":"187","author":[{"given":"Md Haroon Or","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6163","authenticated-orcid":false,"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3657-4781","authenticated-orcid":false,"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-9410","authenticated-orcid":false,"given":"Lipi","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenki","family":"Momohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Hifumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-6782","authenticated-orcid":false,"given":"Ahmed S.","family":"Abdel-Moneim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118104_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2024.105710","article-title":"Dengue virus: etiology, epidemiology, pathobiology, and developments in diagnosis and control - a comprehensive review","volume":"127","author":"Pourzangiabadi","year":"2025","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.biopha.2025.118104_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med J. Armed Forces India"},{"key":"10.1016\/j.biopha.2025.118104_bib3","unstructured":"European Centre for Disease Prevention and Control. Dengue worldwide overview. Situation update, September (2024) Available from: \u3008https:\/\/www.ecdc.europa.eu\/en\/dengue-monthly#:\u223c:text=Situation%20updat%2C%20September%202024,deaths%20have%20been%20reported%20globally\u3009. Accessed 12 October 2024."},{"key":"10.1016\/j.biopha.2025.118104_bib4","unstructured":"World Health Organization, Dengue and severe dengue. 23 April (2023) Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue\u3009. Accessed 12 October 2024."},{"issue":"7446","key":"10.1016\/j.biopha.2025.118104_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118104_bib6","unstructured":"World Health Organization. Dengue and severe dengue. WHO Factsheet [Internet]. (2021) [cited 2024 Oct 6]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue\u3009."},{"key":"10.1016\/j.biopha.2025.118104_bib7","unstructured":"World Health Organization (WHO). Dengue and severe dengue [Internet]. Geneva: WHO; (2022) [cited 2024 Oct 6]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue\u3009."},{"key":"10.1016\/j.biopha.2025.118104_bib8","unstructured":"Centers for Disease Control and Prevention (CDC). Dengue Vaccines [Internet]. Atlanta (GA): CDC; (2022) [cited 2024 Oct 6]. Available from: \u3008https:\/\/www.cdc.gov\/dengue\/hcp\/vaccine\/index.html\u3009."},{"issue":"8","key":"10.1016\/j.biopha.2025.118104_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118104_bib10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118104_bib11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2025.118104_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118104_bib13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acsinfecdis.3c00311","article-title":"Galidesivir triphosphate promotes stalling of dengue-2 virus polymerase immediately prior to incorporation","volume":"9","author":"Deshpande","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118104_bib14","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1038\/s41598-023-29517-9","article-title":"Expanded profiling of remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro","volume":"13","author":"Radoshitzky","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118104_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.606743","article-title":"Repurposing the antiemetic metoclopramide as an antiviral against dengue virus infection in neuronal cells","volume":"10","author":"Shen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.biopha.2025.118104_bib16","doi-asserted-by":"crossref","first-page":"18306","DOI":"10.1039\/D3RA02613B","article-title":"Exploring the inhibitory potential of Nigella sativa against dengue virus NS2B\/NS3 protease and NS5 polymerase using computational approaches","volume":"13","author":"Mukhtar","year":"2023","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.biopha.2025.118104_bib17","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/JVI.02188-08","article-title":"A. Garc\u00eda-Sastre, NS5 of dengue virus mediates STAT2 binding and degradation","volume":"83","author":"Ashour","year":"2009","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118104_bib18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.biopha.2025.118104_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00705-017-3641-5","article-title":"Pharmacophoric characteristics of dengue virus NS2B\/NS3pro inhibitors: a systematic review of the most promising compounds","volume":"163","author":"Leonel","year":"2018","journal-title":"Arch. Virol."},{"issue":"48","key":"10.1016\/j.biopha.2025.118104_bib20","doi-asserted-by":"crossref","first-page":"14834","DOI":"10.1073\/pnas.1514978112","article-title":"Molecular basis for specific viral RNA recognition and 2\u2032-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5)","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.biopha.2025.118104_bib21","doi-asserted-by":"crossref","first-page":"18817","DOI":"10.1074\/jbc.M109.090936","article-title":"Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implications","volume":"285","author":"Luo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2025.118104_bib22","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1322036111","article-title":"Structural basis of Flavivirus NS1 assembly and antibody recognition","volume":"111","author":"Edeling","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"W1","key":"10.1016\/j.biopha.2025.118104_bib23","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.biopha.2025.118104_bib24","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118104_bib25","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model"},{"issue":"W1","key":"10.1016\/j.biopha.2025.118104_bib26","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118104_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.meegid.2017.04.003","article-title":"Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection","volume":"51","author":"Kayesh","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.biopha.2025.118104_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2009.09.018","article-title":"Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA","volume":"163","author":"Moi","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.biopha.2025.118104_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104643","article-title":"Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase","volume":"172","author":"Kato","year":"2019","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118104_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199244","article-title":"Suppression of dengue virus replication by the French maritime pine extract Pycnogenol\u00ae","volume":"339","author":"Hossain","year":"2024","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118104_bib31","first-page":"E12","article-title":"A mouse model for studying dengue virus pathogenesis and immune response","volume":"1171","author":"Williams","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118104_bib32","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1128\/AAC.03368-14","article-title":"BCX4430, a novel nucleoside analog, effectively treats yellow fever in a hamster model","volume":"58","author":"Julander","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2025.118104_bib33","article-title":"Antiviral activity of pimecrolimus against dengue virus type 2 infection in vitro and in vivo","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118104_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","article-title":"Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor","volume":"141","author":"Chan","year":"2017","journal-title":"Antivir. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118104_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bmc.2010.11.017","article-title":"Molecular modeling based approach, synthesis and in vitro assay to new indole inhibitors of hepatitis C NS3\/4A serine protease","volume":"19","author":"Ismail","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118104_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.637266","article-title":"Virtual screening of drug-like compounds as potential inhibitors of the dengue virus NS5 protein","volume":"10","author":"Garc\u00eda-Ariza","year":"2022","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118104_bib37","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.biopha.2025.118104_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257206","article-title":"Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease","volume":"16","author":"Uday","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.118104_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00894-022-05355-w","article-title":"Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies","volume":"28","author":"Purohit","year":"2022","journal-title":"J. Mol. Model"},{"key":"10.1016\/j.biopha.2025.118104_bib40","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1093\/nar\/gkac473","article-title":"Insights into the product release mechanism of dengue virus NS3 helicase","volume":"50","author":"Adler","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2025.118104_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118104_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/vjch.202100145","article-title":"An in silico study on inhibitability of Baloxavir marboxil, Baricitinib, Galidesivir, Nitazoxanide, and Oseltamivir against SARS-CoV-2","volume":"60","author":"Bui","year":"2022","journal-title":"Vietnam J. Chem."},{"key":"10.1016\/j.biopha.2025.118104_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11030-021-10215-5","article-title":"In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase","volume":"26","author":"Celik","year":"2022","journal-title":"Mol. Divers"},{"key":"10.1016\/j.biopha.2025.118104_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.637266","article-title":"Virtual screening of drug-like compounds as potential inhibitors of the dengue virus NS5 protein","volume":"10","author":"Garc\u00eda-Ariza","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2025.118104_bib45","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.3390\/ijms25084376","article-title":"The Inhibition of NS2B\/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection","volume":"25","author":"Starvaggi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.biopha.2025.118104_bib46","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/cmdc.202100246","article-title":"Ligand accessibility insights to the dengue virus NS3-NS2B protease assessed by long-timescale molecular dynamics simulations","volume":"16","author":"Kronenberger","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2025.118104_bib47","doi-asserted-by":"crossref","unstructured":"de Lima Neto D.F., Soares A.P., Zaki Pour S., Ortiz Baez A.S., de Castro Neuhaus P., de Melo Freire C.C., Bonaf\u00e9 C.F.S.. Molecular dynamics suggests antiviral compounds active against Dengue Virus show similar binding patterns to Zika Virus proteins. bioRxiv. https:\/\/doi.org\/10.1101\/309351.","DOI":"10.1101\/309351"},{"key":"10.1016\/j.biopha.2025.118104_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104899","article-title":"Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses","volume":"182","author":"Konkolova","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118104_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2018.07.018","article-title":"Drug repurposing of quinine as antiviral against dengue virus infection","volume":"255","author":"Malakar","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.biopha.2025.118104_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel antiviral activity of bromocriptine against dengue virus replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2025.118104_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.606743","article-title":"Repurposing the antiemetic metoclopramide as an antiviral against dengue virus infection in neuronal cells","volume":"10","author":"Shen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol"},{"issue":"10","key":"10.1016\/j.biopha.2025.118104_bib52","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/v14102150","article-title":"A transcriptomics-based bioinformatics approach for identification and in vitro screening of FDA-approved drugs for repurposing against dengue virus-2","volume":"14","author":"Punekar","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.biopha.2025.118104_bib53","first-page":"997","article-title":"Drug repurposing approaches to fight dengue virus infection and related diseases","volume":"23","author":"Botta","year":"2018","journal-title":"Front Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.biopha.2025.118104_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110129","article-title":"The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?","volume":"143","author":"Dal Moro","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopha.2025.118104_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2217\/fca-2020-0201","article-title":"Targeting the SARS-CoV-2 3CLpro and NO\/cGMP\/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors","volume":"17","author":"Shirvaliloo","year":"2021","journal-title":"Future Cardiol."},{"key":"10.1016\/j.biopha.2025.118104_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13104-018-3417-3","article-title":"Screening of melatonin, \u03b1-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity","volume":"11","author":"Paemanee","year":"2018","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.biopha.2025.118104_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1708-8305.2007.00130.x","article-title":"Phylogenetic analysis of dengue viruses isolated from imported dengue patients: possible aid for determining the countries where infections occurred","volume":"14","author":"Ito","year":"2007","journal-title":"J. Travel Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:56:32Z","timestamp":1759002992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"alternative-id":["S0753332225002987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118104","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repositioning: Identification of potent inhibitors of NS3 protease and NS5 RdRp for control of DENV infection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118104"}}